GenMont Biotech Incorporation (TPE:3164)
18.05
+0.50 (2.85%)
Mar 10, 2026, 1:30 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.55 billion as of March 9, 2026. Its market cap has decreased by -10.50% in one year.
Market Cap
1.55B
Enterprise Value
1.46B
Revenue
391.48M
Ranking
n/a
PE Ratio
46.29
Stock Price
18.05
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.55B, an increase of 72.66%. That is a compound annual growth rate of 2.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.49B |
| Abnova (Taiwan) | 1.47B |
| Meribank Biotech | 1.43B |
| Anti-Microbial Savior BioteQ | 1.68B |
| Great Novel Therapeutics Biotech & Medicals | 1.36B |
| Genomics BioSci & Tech. | 1.74B |
| Enimmune | 1.27B |
| Advagene Biopharma | 1.83B |